Last 12 months
Inside the activity.
2 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 1 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 22, 2026 Filed Sep 23, 2026 14:24 UTC |
Madaus Martin DInterim CEO
|
Tax withholdingCommon | 1,456 | $34.28 | $49,911.68 |
DisclosureSEC source: 0001628280-26-063164 · wk-form4_1790173457.xml · nonDerivative · entry 1 Madaus Martin D · CIK 0001310268 · Interim CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,602 F1 · shares: Shares withheld by the Company to satisfy tax withholding obligations arising from the vesting and settlement on September 22, 2026, of 3,055 restricted stock units held by the Reporting Person. This transaction does not represent a sale of securities by the Reporting Person in the market. Read SEC document |
| September 15, 2026 Filed Sep 17, 2026 00:12 UTC |
Bello Erik J.VP Chief Accounting Officer
|
GrantCommon | 4,586 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-062341 · wk-form4_1789603974.xml · nonDerivative · entry 1 Bello Erik J. · CIK 0002154435 · VP Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,586 F1 · shares: Grant of restricted stock units to the Reporting Person under the Company's Equity Incentive Plan. No amount was paid upon grant of the units. Because the units are payable solely in shares of common stock, they are reported in Table I of this Form 4. The units are subject to time-based vesting and will vest 33-1/3% per year, beginning on September 15, 2027, subject to the terms of the award agreement. Read SEC document |
| September 14, 2026 Filed Sep 17, 2026 01:50 UTC |
Madaus Martin DInterim CEO
|
GrantCommon | 36,653 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-062354 · wk-form4_1789609812.xml · nonDerivative · entry 1 Madaus Martin D · CIK 0001310268 · Interim CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,058 F1 · shares: Grant of restricted stock units to the Reporting Person under the Company Equity Incentive Plan. No amount was paid upon grant of the units. Because the units are payable solely in shares of common stock, they are reported in Table I of this Form 4. The units are subject to time-based vesting and will vest 1/12 per month for twelve months. Read SEC document |
| September 14, 2026 Filed Sep 17, 2026 00:25 UTC |
MARTIN WILLIAM E. IIIPresident Multiomics
|
GrantCommon | 15,272 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-062348 · wk-form4_1789604730.xml · nonDerivative · entry 1 MARTIN WILLIAM E. III · CIK 0001949513 · President Multiomics 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,062 F1 · shares: Grant of restricted stock units to the Reporting Person under the Company's Equity Incentive Plan. No amount was paid upon grant of the units. Because the units are payable solely in shares of common stock, they are reported in Table I of this Form 4. The units are subject to time-based vesting and will vest 50% per year, beginning on September 14, 2027, subject to the terms of the award agreement. Read SEC document |
| September 14, 2026 Filed Sep 17, 2026 00:21 UTC |
Pirogova OlgaSVP and CHRO
|
GrantCommon | 15,272 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-062345 · wk-form4_1789604464.xml · nonDerivative · entry 1 Pirogova Olga · CIK 0002000496 · SVP and CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,225 F1 · shares: Grant of restricted stock units to the Reporting Person under the Company's Equity Incentive Plan. No amount was paid upon grant of the units. Because the units are payable solely in shares of common stock, they are reported in Table I of this Form 4. The units are subject to time-based vesting and will vest 50% per year, beginning on September 14, 2027, subject to the terms of the award agreement. Read SEC document |
| September 14, 2026 Filed Sep 17, 2026 00:19 UTC |
Lin Lawrence Y.EVP, CFO and Treasurer
|
GrantCommon | 30,544 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-062344 · wk-form4_1789604338.xml · nonDerivative · entry 1 Lin Lawrence Y. · CIK 0002045844 · EVP, CFO and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 110,199 F1 · shares: Grant of restricted stock units to the Reporting Person under the Company's Equity Incentive Plan. No amount was paid upon grant of the units. Because the units are payable solely in shares of common stock, they are reported in Table I of this Form 4. The units are subject to time-based vesting and will vest 50% per year, beginning on September 14, 2027, subject to the terms of the award agreement. Read SEC document |
| September 14, 2026 Filed Sep 17, 2026 00:16 UTC |
Starr EphraimSVP, Gen Counsel & Secretary
|
GrantCommon | 15,272 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-062343 · wk-form4_1789604158.xml · nonDerivative · entry 1 Starr Ephraim · CIK 0002069816 · SVP, Gen Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,000 F1 · shares: Grant of restricted stock units to the Reporting Person under the Company's Equity Incentive Plan. No amount was paid upon grant of the units. Because the units are payable solely in shares of common stock, they are reported in Table I of this Form 4. The units are subject to time-based vesting and will vest 50% per year, beginning on September 14, 2027, subject to the terms of the award agreement. Read SEC document |
| August 09, 2026 Filed Aug 11, 2026 20:41 UTC |
Pirogova OlgaSVP and CHRO
|
Tax withholdingCommon | 1,085 | $32.04 | $34,763.40 |
DisclosureSEC source: 0001628280-26-055760 · wk-form4_1786480883.xml · nonDerivative · entry 1 Pirogova Olga · CIK 0002000496 · SVP and CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,953 F1 · shares: Shares withheld by the Company to satisfy tax withholding obligations arising upon the vesting on August 9, 2026. This transaction does not represent a sale of securities by the Reporting Person in the market. Read SEC document |
| July 31, 2026 Filed Aug 4, 2026 22:11 UTC |
Starr EphraimSVP, Gen Counsel & Secretary
|
PurchaseCommon | 335 | $24.17 | $8,096.15 |
DisclosureSEC source: 0001628280-26-052799 · wk-form4_1785881503.xml · nonDerivative · entry 1 Starr Ephraim · CIK 0002069816 · SVP, Gen Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,728 F1 · shares: Purchase by the Reporting Person under the Azenta, Inc. 2017 Employee Stock Purchase Plan. The purchase of shares was exempt from Section 16(b) of the Securities Exchange Act of 1934 pursuant to Rule 16b-3(c) thereunder. Read SEC document |
| May 18, 2026 Filed May 19, 2026 20:10 UTC |
Cornog William LDirector
|
PurchaseCommon | 10,000 | $16.38 | $163,800.00 |
DisclosureSEC source: 0001193125-26-230764 · ownership.xml · nonDerivative · entry 1 Cornog William L · CIK 0001697415 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 19,703 F1 · price: Represents the weighted average price for the shares purchased. The shares were purchased at per-share prices ranging from $16.19 to $16.52. The reporting person will provide to the SEC, the issuer and any stockholder, upon request, full information regarding the number of shares purchased or sold at each separate price. F2 · ownership.nature: Reflects shares held in trusts beneficially owned by the reporting person, of which the reporting person, his spouse and children are beneficiaries, and as to which the reporting person is the trustee and has investment and voting power. Read SEC document |
| May 15, 2026 Filed May 18, 2026 20:10 UTC |
Starr EphraimSVP, Gen Counsel & Secretary
|
Tax withholdingCommon | 3,621 | $16.02 | $58,008.42 |
DisclosureSEC source: 0002069816-26-000002 · ownership.xml · nonDerivative · entry 1 Starr Ephraim · CIK 0002069816 · SVP, Gen Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,393 F1 · shares: The sale of shares by the reporting person to satisfy the reporting person's obligations with respect to withholding taxes in connection with the vesting on May 15, 2026 of 12,593 restricted stock units held by the reporting person. Read SEC document |
| April 28, 2026 Filed Apr 30, 2026 20:15 UTC |
MARTIN WILLIAM E. IIIPresident Multiomics
|
GrantCommon | 17,790 | $24.24 | $431,229.60 |
DisclosureSEC source: 0001949513-26-000008 · ownership.xml · nonDerivative · entry 1 MARTIN WILLIAM E. III · CIK 0001949513 · President Multiomics 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,790 F1 · shares: Grant of restricted stock units to the Reporting Person under the Company's Equity Incentive Plan. No amount was paid upon grant of the units. The units will vest over three years, 33% on Apriil 18, 2027, 33% on Apriil 18, 2028, and 33% on Apriil 18, 2029. Read SEC document |
| February 06, 2026 Filed Feb 6, 2026 23:12 UTC |
Nova Tina SusanDirector
|
GrantCommon | 5,663 | $27.85 | $157,714.55 |
DisclosureSEC source: 0001193125-26-041527 · ownership.xml · nonDerivative · entry 1 Nova Tina Susan · CIK 0001302605 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,772 F1 · shares: Grant of unrestricted shares under the Company's 2020 Equity Incentive Plan. No amount was paid upon grant of the shares. Read SEC document |
| February 05, 2026 Filed Feb 6, 2026 22:47 UTC |
Cornog William LDirector
|
GrantRestricted Stock Unit · Derivative | 5,663 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0001193125-26-041487 · ownership.xml · derivative · entry 1 Cornog William L · CIK 0001697415 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,663 Underlying: Common Stock · 5,663 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Azenta's common stock. The units are fully vested upon grant but the Reporting Person elected to have the settlement deferred until the later of his attainment of age 65 or his separation from service from the company. F2 · price: Grant of Restricted Stock Units under the Company's 2020 Equity Incentive Plan. No amount was paid upon grant of the units. F1 · derivative.exercise_date: Each restricted stock unit represents the right to receive one share of Azenta's common stock. The units are fully vested upon grant but the Reporting Person elected to have the settlement deferred until the later of his attainment of age 65 or his separation from service from the company. F1 · derivative.expiration_date: Each restricted stock unit represents the right to receive one share of Azenta's common stock. The units are fully vested upon grant but the Reporting Person elected to have the settlement deferred until the later of his attainment of age 65 or his separation from service from the company. Read SEC document |
| February 05, 2026 Filed Feb 6, 2026 22:47 UTC |
Madaus Martin DDirector
|
GrantRestricted Stock Unit · Derivative | 5,663 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0001193125-26-041485 · ownership.xml · derivative · entry 1 Madaus Martin D · CIK 0001310268 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,703 Underlying: Common Stock · 5,663 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Azenta's common stock. The units are fully vested upon grant but the Reporting Person elected to have the settlement deferred until the later of his attainment of age 65 or his separation from service from the company. F2 · price: Grant of Restricted Stock Units under the Company's 2020 Equity Incentive Plan. No amount was paid upon grant of the units. F1 · derivative.exercise_date: Each restricted stock unit represents the right to receive one share of Azenta's common stock. The units are fully vested upon grant but the Reporting Person elected to have the settlement deferred until the later of his attainment of age 65 or his separation from service from the company. F1 · derivative.expiration_date: Each restricted stock unit represents the right to receive one share of Azenta's common stock. The units are fully vested upon grant but the Reporting Person elected to have the settlement deferred until the later of his attainment of age 65 or his separation from service from the company. Read SEC document |
| February 05, 2026 Filed Feb 6, 2026 22:46 UTC |
Doshi DipalDirector
|
GrantCommon | 5,663 | $27.85 | $157,714.55 |
DisclosureSEC source: 0001193125-26-041482 · ownership.xml · nonDerivative · entry 1 Doshi Dipal · CIK 0001613084 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,703 F1 · shares: Grant of unrestricted shares under the Company's 2020 Equity Incentive Plan. No amount was paid upon grant of the shares. Read SEC document |
| February 05, 2026 Filed Feb 6, 2026 22:45 UTC |
Casal FrankDirector
|
GrantCommon | 7,243 | $27.85 | $201,717.55 |
DisclosureSEC source: 0001193125-26-041478 · ownership.xml · nonDerivative · entry 1 Casal Frank · CIK 0001891819 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,803 F1 · shares: Grant of unrestricted shares under the Company's 2020 Equity Incentive Plan. No amount was paid upon grant of the shares. Read SEC document |
| February 05, 2026 Filed Feb 6, 2026 22:44 UTC |
McLaughlin EricaDirector
|
GrantCommon | 5,663 | $27.85 | $157,714.55 |
DisclosureSEC source: 0001193125-26-041476 · ownership.xml · nonDerivative · entry 1 McLaughlin Erica · CIK 0001740348 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,521 F1 · shares: Grant of unrestricted shares under the Company's 2020 Equity Incentive Plan. No amount was paid upon grant of the shares. Read SEC document |
| February 05, 2026 Filed Feb 6, 2026 22:43 UTC |
Davis Robyn CDirector
|
GrantRestricted Stock Unit · Derivative | 5,663 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0001193125-26-041473 · ownership.xml · derivative · entry 1 Davis Robyn C · CIK 0001580601 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,662 Underlying: Common Stock · 5,663 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Azenta's common stock. The units are fully vested upon grant but the Reporting Person elected to have the settlement deferred until the later of his attainment of age 65 or his separation from service from the company. F2 · price: Grant of Restricted Stock Units under the Company's 2020 Equity Incentive Plan. No amount was paid upon grant of the units. F1 · derivative.exercise_date: Each restricted stock unit represents the right to receive one share of Azenta's common stock. The units are fully vested upon grant but the Reporting Person elected to have the settlement deferred until the later of his attainment of age 65 or his separation from service from the company. F1 · derivative.expiration_date: Each restricted stock unit represents the right to receive one share of Azenta's common stock. The units are fully vested upon grant but the Reporting Person elected to have the settlement deferred until the later of his attainment of age 65 or his separation from service from the company. Read SEC document |
| February 05, 2026 Filed May 12, 2026 20:01 UTC |
Koffey QuentinDirector
|
GrantCommon Stock | 5,663 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-059359 · tm2614389-1_4seq1.xml · nonDerivative · entry 1 Koffey Quentin · CIK 0001984174 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,698 F1 · shares: Annual grant of unrestricted shares under the Issuer's 2020 Equity Incentive Plan in connection with the Reporting Person's service on the Issuer's Board of Directors (the "Board"). The number of shares was determined based on an annual grant amount of $215,000 and a price per share of $37.97 based on the average daily closing price for the 20 trading-day period immediately preceding and including February 5, 2026. F2 · price: No amount was paid upon grant of the shares. Read SEC document |
| November 24, 2025 Filed Nov 26, 2025 01:23 UTC |
Lin Lawrence Y.EVP, CFO and Treasurer
|
GrantCommon | 36,681 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-297842 · ownership.xml · nonDerivative · entry 1 Lin Lawrence Y. · CIK 0002045844 · EVP, CFO and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,655 F1 · shares: Represents the grant of restricted stock units ("RSUs"). No amount was paid upon grant of the RSUs. The number of RSUs granted was determined by dividing the target award value by the average closing price of the Company's common stock over the 20 trading days ending on the date of grant. The RSUs are subject to time-based vesting and will vest 33-1/3% per year, beginning on November 24, 2026. Read SEC document |
| November 24, 2025 Filed Nov 26, 2025 01:26 UTC |
Marotta JohnDirector · President and CEO
|
GrantCommon | 122,269 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-297847 · ownership.xml · nonDerivative · entry 1 Marotta John · CIK 0001882058 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 217,268.78 F1 · shares: Represents the grant of restricted stock units ("RSUs"). No amount was paid upon grant of the RSUs. The number of RSUs granted was determined by dividing the target award value by the average closing price of the Company's common stock over the 20 trading days ending on the date of grant. The RSUs are subject to time-based vesting and will vest 33-1/3% per year, beginning on November 24, 2026. Read SEC document |
| November 24, 2025 Filed Nov 26, 2025 01:20 UTC |
Pirogova OlgaSVP and CHRO
|
GrantCommon | 16,303 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-297837 · ownership.xml · nonDerivative · entry 1 Pirogova Olga · CIK 0002000496 · SVP and CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,038 F1 · shares: Represents the grant of restricted stock units ("RSUs"). No amount was paid upon grant of the RSUs. The number of RSUs granted was determined by dividing the target award value by the average closing price of the Company's common stock over the 20 trading days ending on the date of grant. The RSUs are subject to time-based vesting and will vest 33-1/3% per year, beginning on November 24, 2026. Read SEC document |
| November 24, 2025 Filed Nov 26, 2025 01:11 UTC |
Starr EphraimSVP, Gen Counsel & Secretary
|
GrantCommon | 34,235 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-297823 · ownership.xml · nonDerivative · entry 1 Starr Ephraim · CIK 0002069816 · SVP, Gen Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,014 F1 · shares: Represents the grant of restricted stock units ("RSUs"). No amount was paid upon grant of the RSUs. The number of RSUs granted was determined by dividing the target award value by the average closing price of the Company's common stock over the 20 trading days ending on the date of grant. The RSUs are subject to time-based vesting and will vest 33-1/3% per year, beginning on November 24, 2026. Read SEC document |
| November 24, 2025 Filed Nov 26, 2025 01:15 UTC |
Zhou GingerSVP and GM, Multiomics
|
GrantCommon | 13,042 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-297830 · ownership.xml · nonDerivative · entry 1 Zhou Ginger · CIK 0001953934 · SVP and GM, Multiomics 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,755 F1 · shares: Represents the grant of restricted stock units ("RSUs"). No amount was paid upon grant of the RSUs. The number of RSUs granted was determined by dividing the target award value by the average closing price of the Company's common stock over the 20 trading days ending on the date of grant. The RSUs are subject to time-based vesting and will vest 33-1/3% per year, beginning on November 24, 2026. Read SEC document |
| November 24, 2025 Filed Dec 3, 2025 23:29 UTC Amendment |
Marotta JohnDirector · President and CEO
|
GrantCommon | 118,194 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-307099 · ownership.xml · nonDerivative · entry 1 Marotta John · CIK 0001882058 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 213,193.78 F1 · shares: This amendment to Form 4 is being filed to correct the number of restricted stock units ("RSUs") previously reported. The original Form 4 filed on November 25, 2025 incorrectly stated that 122,269 RSUs were acquired. The correct number is 118,194 RSUs. As a result of this correction, the total number of securities beneficially owned following the reported transaction has also been revised to 213,193.78. All other information in the original Form 4 remains unchanged. F1 · balance_after: This amendment to Form 4 is being filed to correct the number of restricted stock units ("RSUs") previously reported. The original Form 4 filed on November 25, 2025 incorrectly stated that 122,269 RSUs were acquired. The correct number is 118,194 RSUs. As a result of this correction, the total number of securities beneficially owned following the reported transaction has also been revised to 213,193.78. All other information in the original Form 4 remains unchanged. Read SEC document |
| November 14, 2025 Filed Nov 17, 2025 21:54 UTC |
Zhou GingerSVP and GM, Multiomics
|
Tax withholdingCommon | 1,118 | $29.75 | $33,260.50 |
DisclosureSEC source: 0001193125-25-284747 · ownership.xml · nonDerivative · entry 1 Zhou Ginger · CIK 0001953934 · SVP and GM, Multiomics 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,713 F1 · shares: The withholding of shares from the reporting person to satisfy the reporting person's obligations with respect to withholding taxes in connection with the vesting on November 15, 2025 of 4,582 restricted stock units held by the reporting person. Read SEC document |
| November 14, 2025 Filed Nov 17, 2025 21:52 UTC |
Pirogova OlgaSVP and CHRO
|
Tax withholdingCommon | 1,553 | $29.75 | $46,201.75 |
DisclosureSEC source: 0001193125-25-284743 · ownership.xml · nonDerivative · entry 1 Pirogova Olga · CIK 0002000496 · SVP and CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,735 F1 · shares: The withholding of shares from the reporting person to satisfy the reporting person's obligations with respect to withholding taxes in connection with the vesting on November 15, 2025 of 4,529 restricted stock units held by the reporting person. Read SEC document |
| November 14, 2025 Filed Nov 17, 2025 21:48 UTC |
Lin Lawrence Y.EVP, CFO and Treasurer
|
Tax withholdingCommon | 3,039 | $29.75 | $90,410.25 |
DisclosureSEC source: 0001193125-25-284737 · ownership.xml · nonDerivative · entry 1 Lin Lawrence Y. · CIK 0002045844 · EVP, CFO and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,974 F1 · shares: The withholding of shares from the reporting person to satisfy the reporting person's obligations with respect to withholding taxes in connection with the vesting on November 15, 2025 of 10,566 restricted stock units held by the reporting person. Read SEC document |
| November 14, 2025 Filed Nov 17, 2025 21:45 UTC |
Marotta JohnDirector · President and CEO
|
Tax withholdingCommon | 10,980 | $29.75 | $326,655.00 |
DisclosureSEC source: 0001193125-25-284729 · ownership.xml · nonDerivative · entry 1 Marotta John · CIK 0001882058 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 94,999.78 F1 · shares: The withholding of shares from the reporting person to satisfy the reporting person's obligations with respect to withholding taxes in connection with the vesting on November 15, 2025 of 27,872 restricted stock units held by the reporting person. Read SEC document |
| September 10, 2025 Filed Sep 12, 2025 20:10 UTC |
Marotta JohnDirector · President and CEO
|
SaleCommon | 316 | $29.41 | $9,293.56 |
DisclosureSEC source: 0000950170-25-114528 · ownership.xml · nonDerivative · entry 1 Marotta John · CIK 0001882058 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 105,979.78 F1 · shares: The sale of shares by the reporting person to satisfy the reporting person's obligations with respect to withholding taxes in connection with the vesting on September 9, 2025 of 1,091 restricted stock units held by the reporting person. Read SEC document |
| August 12, 2025 Filed Aug 13, 2025 20:44 UTC |
Pirogova OlgaSVP and CHRO
|
Disposition to issuerCommon | 1,085 | $28.54 | $30,965.90 |
DisclosureSEC source: 0000950170-25-108106 · ownership.xml · nonDerivative · entry 1 Pirogova Olga · CIK 0002000496 · SVP and CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,288 F1 · shares: The sale of shares by the reporting person to satisfy the reporting person's obligations with respect to withholding taxes in connection with the vesting on August 9, 2025 of 3,167 restricted stock units held by the reporting person. Read SEC document |
| August 12, 2025 Filed Aug 13, 2025 20:47 UTC |
Zhou GingerSVP and GM, Multiomics
|
Disposition to issuerCommon | 1,085 | $28.54 | $30,965.90 |
DisclosureSEC source: 0000950170-25-108118 · ownership.xml · nonDerivative · entry 1 Zhou Ginger · CIK 0001953934 · SVP and GM, Multiomics 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,831 F1 · shares: The sale of shares by the reporting person to satisfy the reporting person's obligations with respect to withholding taxes in connection with the vesting on August 9, 2025 of 3,167 restricted stock units held by the reporting person. Read SEC document |
| August 12, 2025 Filed Nov 14, 2025 21:10 UTC Amendment |
Pirogova OlgaSVP and CHRO
|
SaleCommon | 1,085 | $28.54 | $30,965.90 |
DisclosureSEC source: 0001193125-25-282948 · ownership.xml · nonDerivative · entry 1 Pirogova Olga · CIK 0002000496 · SVP and CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,288 F1 · date: This amendment is being filed to include the Power of Attorney authorizing the undersigned to sign and file Forms 3, 4, and 5 on behalf of the reporting person, which was inadvertently not included with the original Form 4 filed on August 13, 2025. F2 · kind: This amendment is being filed to correct an administrative error in the transaction code reported in the original Form 4 filed on August 13, 2025. The transaction was inadvertently reported using transaction code "D" instead of the correct code "S." Read SEC document |
| August 12, 2025 Filed Nov 14, 2025 21:10 UTC Amendment |
Zhou GingerSVP and GM, Multiomics
|
SaleCommon | 1,085 | $28.54 | $30,965.90 |
DisclosureSEC source: 0001193125-25-282944 · ownership.xml · nonDerivative · entry 1 Zhou Ginger · CIK 0001953934 · SVP and GM, Multiomics 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,831 F1 · date: This amendment is being filed to include the Power of Attorney authorizing the undersigned to sign and file Forms 3, 4, and 5 on behalf of the reporting person, which was inadvertently not included with the original Form 4 filed on August 13, 2025. F2 · kind: This amendment is being filed to correct an administrative error in the transaction code reported in the original Form 4 filed on August 13, 2025. The transaction was inadvertently reported using transaction code "D" instead of the correct code "S." Read SEC document |
| August 11, 2025 Filed Aug 12, 2025 20:05 UTC |
Lin Lawrence Y.EVP, CFO and Treasurer
|
PurchaseCommon | 2,500 | $27.96 | $69,900.00 |
DisclosureSEC source: 0000950170-25-107291 · ownership.xml · nonDerivative · entry 1 Lin Lawrence Y. · CIK 0002045844 · EVP, CFO and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,013 F1 · shares: Open market purchase. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 20:30 UTC |
Marotta JohnDirector · President and CEO
|
GrantCommon | 1,000 | $25.99 | $25,990.00 |
DisclosureSEC source: 0000950170-25-081659 · ownership.xml · nonDerivative · entry 1 Marotta John · CIK 0001882058 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 107,295.78 F1 · shares: Open market purchase. Read SEC document |
| June 02, 2025 Filed Nov 14, 2025 21:10 UTC Amendment |
Marotta JohnDirector · President and CEO
|
PurchaseCommon | 1,000 | $25.99 | $25,990.00 |
DisclosureSEC source: 0001193125-25-282947 · ownership.xml · nonDerivative · entry 1 Marotta John · CIK 0001882058 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 107,295.78 F1 · date: This amendment is being filed to include the Power of Attorney authorizing the undersigned to sign and file Forms 3, 4, and 5 on behalf of the reporting person, which was inadvertently not included with the original Form 4 filed on June 4, 2025. F2 · kind: This amendment is being filed to correct an administrative error in the transaction code reported in the original Form 4 filed on June 4, 2025. The transaction was inadvertently reported using transaction code "A" instead of the correct code "P." Read SEC document |
| May 30, 2025 Filed Jun 3, 2025 20:10 UTC |
Malus Alan JDirector
|
GrantCommon | 12,000 | $26.65 | $319,800.00 |
DisclosureSEC source: 0000950170-25-080924 · ownership.xml · nonDerivative · entry 1 Malus Alan J · CIK 0001380163 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,035 F1 · shares: Open market purchase. Read SEC document |
| May 30, 2025 Filed Nov 14, 2025 21:10 UTC Amendment |
Malus Alan JDirector
|
PurchaseCommon | 12,000 | $26.65 | $319,800.00 |
DisclosureSEC source: 0001193125-25-282946 · ownership.xml · nonDerivative · entry 1 Malus Alan J · CIK 0001380163 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,035 F1 · date: This amendment is being filed to include the Power of Attorney authorizing the undersigned to sign and file Forms 3, 4, and 5 on behalf of the reporting person, which was inadvertently not included with the original Form 4 filed on June 3, 2025. F2 · kind: This amendment is being filed to correct an administrative error in the transaction code reported in the original Form 4 filed on June 3, 2025. The transaction was inadvertently reported using transaction code "A" instead of the correct code "P." Read SEC document |
| May 20, 2025 Filed May 20, 2025 20:07 UTC |
Cornog William LDirector
|
GrantCommon | 2,748 | $27.37 | $75,212.76 |
DisclosureSEC source: 0000950170-25-075180 · ownership.xml · nonDerivative · entry 3 Cornog William L · CIK 0001697415 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 21,755 F3 · price: Represents the weighted average price for the shares purchased. The shares were purchased at per-share prices ranging from $27.16 to $27.49. The reporting person will provide to the SEC, the issuer and any stockholder, upon request, full information regarding the number of shares purchased or sold at each separate price. F1 · ownership.nature: Reflects shares held in trusts beneficially owned by the reporting person, of which the reporting person, his spouse and children are beneficiaries, and as to which the reporting person is the trustee and has investment and voting power. Read SEC document |
| May 20, 2025 Filed Nov 25, 2025 21:28 UTC Amendment |
Cornog William LDirector
|
PurchaseCommon | 2,748 | $27.37 | $75,212.76 |
DisclosureSEC source: 0001193125-25-297311 · ownership.xml · nonDerivative · entry 3 Cornog William L · CIK 0001697415 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,795 F1 · kind: This amendment is being filed to correct an administrative error in the transaction code reported in the original Form 4 filed on May 20,, 2025. The transaction was inadvertently reported using transaction code "A" instead of the correct code "P." F4 · balance_after: The original Form 4, filed on May 20, 2025, is being amended by this Form 4 Amendment to correct an administrative error which miscalculated the amount of 21,755 beneficially owned shares after the purchase of 2,748 shares when in fact the correct number of beneficially owned shares was 25,795. As a result of this administrative error, the number of shares beneficially owned by the reporting person following the corrected transaction reflects a reduction in the number of shares reported as beneficially owned. Read SEC document |
| May 19, 2025 Filed May 20, 2025 20:07 UTC |
Cornog William LDirector
|
GrantCommon | 4,152 | $26.98 | $112,020.96 |
DisclosureSEC source: 0000950170-25-075180 · ownership.xml · nonDerivative · entry 2 Cornog William L · CIK 0001697415 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 19,007 F2 · price: Represents the weighted average price for the shares purchased. The shares were purchased at per-share prices ranging from $26.75 to $27.00. The reporting person will provide to the SEC, the issuer and any stockholder, upon request, full information regarding the number of shares purchased or sold at each separate price. F1 · ownership.nature: Reflects shares held in trusts beneficially owned by the reporting person, of which the reporting person, his spouse and children are beneficiaries, and as to which the reporting person is the trustee and has investment and voting power. Read SEC document |
| May 19, 2025 Filed Nov 25, 2025 21:28 UTC Amendment |
Cornog William LDirector
|
PurchaseCommon | 4,152 | $26.98 | $112,020.96 |
DisclosureSEC source: 0001193125-25-297311 · ownership.xml · nonDerivative · entry 2 Cornog William L · CIK 0001697415 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,047 F1 · kind: This amendment is being filed to correct an administrative error in the transaction code reported in the original Form 4 filed on May 20,, 2025. The transaction was inadvertently reported using transaction code "A" instead of the correct code "P." F3 · balance_after: The original Form 4, filed on May 20, 2025, is being amended by this Form 4 Amendment to correct an administrative error which miscalculated the amount of 19,007 beneficially owned shares after the purchase of 4,152 shares when in fact the correct number of beneficially owned shares was 23,047. As a result of this administrative error, the number of shares beneficially owned by the reporting person following the corrected transaction reflects a reduction in the number of shares reported as beneficially owned. Read SEC document |
| May 16, 2025 Filed May 20, 2025 20:07 UTC |
Cornog William LDirector
|
GrantCommon | 100 | $26.50 | $2,650.00 |
DisclosureSEC source: 0000950170-25-075180 · ownership.xml · nonDerivative · entry 1 Cornog William L · CIK 0001697415 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 14,855 F1 · ownership.nature: Reflects shares held in trusts beneficially owned by the reporting person, of which the reporting person, his spouse and children are beneficiaries, and as to which the reporting person is the trustee and has investment and voting power. Read SEC document |
| May 16, 2025 Filed Nov 25, 2025 21:28 UTC Amendment |
Cornog William LDirector
|
PurchaseCommon | 100 | $26.50 | $2,650.00 |
DisclosureSEC source: 0001193125-25-297311 · ownership.xml · nonDerivative · entry 1 Cornog William L · CIK 0001697415 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,895 F1 · kind: This amendment is being filed to correct an administrative error in the transaction code reported in the original Form 4 filed on May 20,, 2025. The transaction was inadvertently reported using transaction code "A" instead of the correct code "P." F2 · balance_after: The original Form 4, filed on May 20, 2025, is being amended by this Form 4 Amendment to correct an administrative error which miscalculated the amount of 14,855 beneficially owned shares after the purchase of 100 shares when in fact the correct number of beneficially owned shares was 18,895. As a result of this administrative error, the number of shares beneficially owned by the reporting person following the corrected transaction reflects a reduction in the number of shares reported as beneficially owned. Read SEC document |
| May 15, 2025 Filed May 27, 2025 22:30 UTC |
Starr EphraimSVP, Gen Counsel & Secretary
|
GrantCommon | 37,779 | $26.71 | $1,009,077.09 |
DisclosureSEC source: 0000950170-25-077926 · ownership.xml · nonDerivative · entry 1 Starr Ephraim · CIK 0002069816 · SVP, Gen Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,779 F1 · shares: Grant of restricted stock units to the Reporting Person under the Company's Equity Incentive Plan. No amount was paid upon grant of the units. The units will vest over three years, 33% on May 15, 2026, 33% on May 15, 2027, and 33% on May 15, 2028. Read SEC document |
| May 09, 2025 Filed May 12, 2025 20:05 UTC |
Lin Lawrence Y.EVP, CFO and Treasurer
|
GrantCommon | 4,000 | $27.49 | $109,960.00 |
DisclosureSEC source: 0000950170-25-069158 · ownership.xml · nonDerivative · entry 2 Lin Lawrence Y. · CIK 0002045844 · EVP, CFO and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,513 F1 · shares: Open market purchase. F2 · price: Represents the weighted average price for the shares purchased. The shares were purchased at per-share prices ranging from $27.37 to $27.70. The reporting person will provide to the SEC, the issuer and any stockholder, upon request, full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| May 09, 2025 Filed May 12, 2025 20:05 UTC |
Marotta JohnDirector · President and CEO
|
GrantCommon | 1,796.165 | $27.84 | $50,005.23 |
DisclosureSEC source: 0000950170-25-069157 · ownership.xml · nonDerivative · entry 2 Marotta John · CIK 0001882058 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 106,295.78 F1 · shares: Open market purchase. F3 · price: Represents the weighted average price for the shares purchased on May 9, 2025. The shares were purchased at per-share prices ranging from $27.39 to $27.84. The reporting person will provide to the SEC, the issuer and any stockholder, upon request, full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| May 09, 2025 Filed Jun 4, 2025 20:10 UTC Amendment |
Marotta JohnDirector · President and CEO
|
GrantCommon | 1,796.165 | $27.49 | $49,376.58 |
DisclosureSEC source: 0000950170-25-081626 · ownership.xml · nonDerivative · entry 2 Marotta John · CIK 0001882058 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 106,295.78 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.